Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Drug Intelligence & Clinical Pharmacy|April 1, 1987
Efficacy of adjunctive carbamazepine in the treatment of chronic schizophreniaJ M Herrera, J J Sramek, J F CostaDICP : the Annals of Pharmacotherapy|January 1, 1990
Patterns of neuroleptic usage in continuously hospitalized chronic schizophrenic patients: evidence for development of drug toleranceJ J Sramek, V Gaurano, J M Herrera, et al.International Journal of Psychosomatics : Official Publication of the International Psychosomatics Institute|January 1, 1991
Adjunctive clonazepam in the treatment of chronic schizophreniaJ M Herrera, W A Alvarez, J P Freinhar, et al.The Annals of Pharmacotherapy|December 10, 1997
Ethnicity and antipsychotic responseE J Frackiewicz, J J Sramek, J M Herrera, et al.Drug Intelligence & Clinical Pharmacy|March 1, 1988
Pharmacy-based screening program for tardive dyskinesiaT N Ahrens, J J Sramek, J M Herrera, et al.The Journal of Nervous and Mental Disease|September 1, 1988
High potency neuroleptics and violence in schizophrenicsJ N Herrera, J J Sramek, J F Costa, et al.Revue Neurologique|December 3, 1998
Exploratory studies: implications for drug development in Alzheimer's diseaseN R Cutler, J J SramekExpert Opinion on Investigational Drugs|November 4, 2000
Ongoing trials in Alzheimer's diseaseJ J Sramek, N R CutlerAlzheimer Disease and Associated Disorders|February 24, 2001
RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?J J Sramek, N R CutlerProgress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2001
Review of the next generation of Alzheimer's disease therapeutics: challenges for drug developmentN R Cutler, J J SramekPageof 13